Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Sales Outlook
1. Kenvue (KVUE) reported better-than-expected Q1 earnings. 2. Adjusted earnings per share were $0.24, above analysts' forecasts. 3. 2025 net sales growth is now projected at 1% to 3%. 4. Operating income margins are expected to decline due to tariffs. 5. Kenvue appointed Amit Banati as the new CFO.